VIB-VUB researchers have developed a patient-relevant lung adenocarcinoma model combined with SEPARATE-Seq technology to ...
Dr Aaron Wenger reveals how improvements in long-read sequencing technology is enabling the elucidation of complex disease ...
Dr Christopher Saunter is the co-founder and Chief Technology Officer of Magnitude Biosciences, a UK-based contract research ...
For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...
Madison have reported a new approach to forming carbon-nitrogen bonds, a critical step in the synthesis of amines widely used ...
A novel microphysiological system using ovarian follicles enables physiologically relevant three-dimensional angiogenesis ...
Researchers at ETH Zurich have developed an automated system that uses infrared imaging and artificial intelligence to assess ...
In the wake of recent government policy aimed at actively replacing animal models in drug discovery, we consider a possible ...
Aaron Wenger is a senior director and principal scientist at Pacific Biosciences, where he oversees the long-read sequencing ...
All Opinion and interviews articles in Drug Target Review ...
A new study has revealed that age-related clonal haematopoiesis accelerates aortic aneurysm growth through RANK/RANKL signalling, meaning that repurposing osteoporosis drugs targeting this pathway ...
ELRIG is launching its first major US event, Drug Discovery USA 2026, at Pfizer’s Cambridge, Massachusetts facility on 16–17 June. The free-to-attend conference will bring together European and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results